DK3355884T3
(en )
2021-08-02
TETRAHYDRO-1H-PYRIDO [3,4-B] INDOL ANTIOSTROGEN MEDICINES
IL246373A0
(en )
2016-08-31
Pyrimidinyloxy benzene derivatives as herbicides
MA40774A
(en )
2017-08-08
DIARYLEUREA DERIVATIVES AS KINASE P38 INHIBITORS
MA41140A
(en )
2017-10-17
2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS PARG INHIBITORS
DK3253762T3
(en )
2021-07-19
9H-PYRROLO-DIPYRIDINE DERIVATIVES.
DK3201196T3
(en )
2021-09-06
Condensed, pentacyclic imidazole derivatives
DK3227297T3
(en )
2021-04-06
4,6-SUBSTITUTED-PYRAZOLO [1,5-A] PYRAZINES LIKE JANUS CHINASE INHIBITORS
ZA201701814B
(en )
2018-05-30
Triazolo[4,5-d]pyrimidines as agonists of the cannabinoid receptor 2
DK3672951T3
(en )
2023-11-20
QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
EP3137074A4
(en )
2017-11-15
Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
MA39822A
(en )
2018-02-06
BICYCLE PYRIMIDINE DERIVATIVES
IL247773A0
(en )
2016-11-30
5,6-disubstituted pyridine-2-carboxamides as cannabinoid receptor agonists
ZA201701131B
(en )
2019-07-31
Novel 2,5-substituted pyrimidines as pde4 inhibitors
EP3038466A4
(en )
2017-01-18
2,2-difluorodioxolo a2a receptor antagonists
SI2991988T1
(en )
2017-09-29
Pyrrolo(2,3-d)pyrimidine derivatives as cb2 receptor agonists
DK3126486T3
(en )
2019-10-14
IMMUNASSAY USING THE Catch Conjugate
IL247817A0
(en )
2016-11-30
Pyridine-2-amides useful as cb2 agonists
ZA201701132B
(en )
2019-07-31
Novel 2,5-substituted pyrimidines as pde inhibitors
DK3661941T3
(en )
2023-03-13
THIAZOLOPYRIDE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
HK1244789B
(en )
2019-12-06
Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
EP3253761A4
(en )
2018-06-20
3,3-difluoro-piperidine derivatives as nr2b nmda receptor antagonists
DK3372589T3
(en )
2021-12-06
Pyrimidine derivatives
SG11201803584RA
(en )
2018-05-30
1,4-dicarbonyl-piperidyl derivatives
HK1254800A1
(en )
2019-07-26
2,3,4,5-tetrahydropyridin-6-amine derivatives
TH1501006629A
(en )
2017-09-14
Pirrolo[2,3-d]pyrimidine derivatives as agonists of the CB2 receptor.